Asthma and exercise-induced bronchoconstriction in athletes: Diagnosis, treatment, and anti-doping challenges
Research output: Contribution to journal › Review › Research › peer-review
Standard
Asthma and exercise-induced bronchoconstriction in athletes: Diagnosis, treatment, and anti-doping challenges. / Hostrup, Morten; Hansen, Erik S; Rasmussen, Søren M; Jessen, Søren; Backer, Vibeke.
In: Scandinavian Journal of Medicine & Science in Sports, Vol. 34, No. 1, e14358, 2023.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Asthma and exercise-induced bronchoconstriction in athletes: Diagnosis, treatment, and anti-doping challenges
AU - Hostrup, Morten
AU - Hansen, Erik S
AU - Rasmussen, Søren M
AU - Jessen, Søren
AU - Backer, Vibeke
N1 - This article is protected by copyright. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Athletes often experience lower airway dysfunction, such as asthma and exercise-induced bronchoconstriction (EIB), which affects more than half the athletes in some sports, not least in endurance sports. Symptoms include coughing, wheezing, and breathlessness, alongside airway narrowing, hyperresponsiveness, and inflammation. Early diagnosis and management are essential. Not only because untreated or poorly managed asthma and EIB potentially affects competition performance and training, but also because untreated airway inflammation can result in airway epithelial damage, remodeling, and fibrosis. Asthma and EIB do not hinder performance, as advancements in treatment strategies have made it possible for affected athletes to compete at the highest level. However, practitioners and athletes must ensure that the treatment complies with general guidelines and anti-doping regulations to prevent the risk of a doping sanction because of inadvertently exceeding specified dosing limits. In this review, we describe considerations and challenges in diagnosing and managing athletes with asthma and EIB. We also discuss challenges facing athletes with asthma and EIB, while also being subject to anti-doping regulations.
AB - Athletes often experience lower airway dysfunction, such as asthma and exercise-induced bronchoconstriction (EIB), which affects more than half the athletes in some sports, not least in endurance sports. Symptoms include coughing, wheezing, and breathlessness, alongside airway narrowing, hyperresponsiveness, and inflammation. Early diagnosis and management are essential. Not only because untreated or poorly managed asthma and EIB potentially affects competition performance and training, but also because untreated airway inflammation can result in airway epithelial damage, remodeling, and fibrosis. Asthma and EIB do not hinder performance, as advancements in treatment strategies have made it possible for affected athletes to compete at the highest level. However, practitioners and athletes must ensure that the treatment complies with general guidelines and anti-doping regulations to prevent the risk of a doping sanction because of inadvertently exceeding specified dosing limits. In this review, we describe considerations and challenges in diagnosing and managing athletes with asthma and EIB. We also discuss challenges facing athletes with asthma and EIB, while also being subject to anti-doping regulations.
KW - Faculty of Science
KW - Exercise-induced bronchoconstriction
KW - EIB
KW - Hyperresponsiveness
KW - AHR
KW - Asthma
KW - Exercise
KW - Training
KW - Physical activity
U2 - 10.1111/sms.14358
DO - 10.1111/sms.14358
M3 - Review
C2 - 36965010
VL - 34
JO - Scandinavian Journal of Medicine & Science in Sports
JF - Scandinavian Journal of Medicine & Science in Sports
SN - 0905-7188
IS - 1
M1 - e14358
ER -
ID: 340363194